DiagnostykaS.A.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-09-02
Share capital
33 756 500,00 PLN
Activity description

Diagnostyka is a medical laboratory company that offers blood tests, allergy tests, genetic testing, and prenatal testing, with the option for home sample collection. They provide online results and free interpretation of test results, along with various health packages available for purchase. The company also emphasizes preventive health measures and offers consultations through their updated application.

Registered address
ul. Prof. Michała Życzkowskiego 16, 31-864 Kraków, Poland
Website
diag.plWebsite active
Email
Email address current
Phone
Social media
Electronic delivery address
AE:PL-12592-53112-VFETU-15

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Stock quotes

PLN 158.00
-1.00 (-0.63%)
157.50158.00158.50159.00158.0010:0012:0014:0016:00
Open
PLN 158.20
High
PLN 159.00
Low
PLN 157.30
Volume
21.8K
Avg. vol.
31.79K
Market cap
PLN 5.33B
P/E ratio
20.93
EPS
PLN 7.55
Shares outstanding
33.76M
52-week
PLN 155.50 – 164.00
Dividend yield
2.78%
Dividend
PLN 4.40
Ex dividend date
Jun 1, 2026
Exchange
GPW Main Market

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 184.50mUSD 25.68mUSD 15.50m
Q1 2026USD 181.23mUSD 33.24mUSD 22.30m
Q4 2025USD 155.27mUSD 16.82mUSD 9.26m
Q3 2025USD 153.78mUSD 25.29mUSD 19.60m

Results for Q3 2026:Nov 26, 2026

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 609.61mMedianUSD 91.95kAverageUSD 1.53m
Net profit
This companyUSD 65.76mMedianUSD 2.48kAverageUSD 176.58k
Operating costs
This companyUSD 512.69mMedianUSD 83.37kAverageUSD 1.29m
Assets
This companyUSD 519.72mMedianUSD 40.46kAverageUSD 1.14m

Bank accounts

Registered as a VAT taxpayer on 2010-07-20. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Dec 2, 2021Financial statement published

Public aid

9 public aid cases recorded, with a total value of $1,282,253.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
Investment aid for charging or refuelling infrastructure
–

European Funds

ProjectEU co-financing
System automatycznej predykcji badań laboratoryjnych oraz optymalizacji kontroli jakości i obciążenia pracy analizatorów działający w oparciu o machine learning
$799.2K

Tenders

46 tenders recorded as contractor: 19 national ($696,789) and 27 EU ($15,160,904).

SubjectAmount
Konkurs na udzielenie zamówienia na badania diagnostyki laboratoryjnej, serologii i mikrobiologii wraz z najmem pomieszczeń dla szpitala w Konstancinie-Jeziornie, przy ul. Wierzejewskiego 12.
–
Badania genetyczne
$481.8K
KBL/2/2026 - Konkurs ofert w zakresie realizacji badań diagnostycznych – laboratoryjnych i genetycznych dla Instytutu „CZMP”
$176.7K

Public sector contracts

Diagnostyka is the contractor in 158 public sector contracts, worth PLN 34.55m in total. They were signed with 65 public buyers.

Public buyerValue
Uniwersytecki Szpital Dziecięcy w KrakowiePLN 185.18
Uniwersytecki Szpital Dziecięcy w KrakowiePLN 277.77
Uniwersytecki Szpital Dziecięcy w KrakowiePLN 185.18
Regionalne Centrum Krwiodawstwa I Krwiolecznictwa w BiałymstokuPLN 19,804
Uniwersytecki Szpital Dziecięcy w KrakowiePLN 184.25

National Health Fund (NFZ) contracts

Diagnostyka has been an NFZ healthcare provider since 2009. In 2026 it is performing 27 contracts with a total value of USD 8.85m. All its contracts were worth USD 75.92m in total.

NFZ contract value by year (in m USD)

Type of careNFZ branchContractsValue in 2026
Świadczenia zdrowotne kontraktowane odrębnieopolskie2USD 1.99m
Profilaktyczne programy zdrowotnedolnośląskie1USD 1.04m
Profilaktyczne programy zdrowotnemałopolskie1USD 787.95k
Profilaktyczne programy zdrowotneśląskie1USD 673.32k
Świadczenia zdrowotne kontraktowane odrębniedolnośląskie1USD 517.07k

Trademarks

Diagnostyka holds 7 active trademarks registered with the Polish Patent Office. 5 applications are pending. 1 mark has expired or was not registered. The first mark was filed in 2023.

MarkProtected until
Diagnostyka+ Więcej dla zdrowiaJan 11, 2036
Mark without a word element(figurative)Nov 25, 2035
KRWINKA MALWINKANov 25, 2035
zdrowowieczność(word)May 2, 2035
longevityJan 19, 2034

Regulatory authorisations

AuthorityTypeStatus
Waste generation Active

Authorized Representatives

Dariusz Zowczak – Vice President of the Management Board
Marta Rogalska Kupiec – Vice President of the Management Board
Jakub Józef Swadźba – President of the Management Board
Jakub Tatak – Vice President of the Management Board
Jaromir Pelczarski – Vice President of the Management Board

Manner of representation

If the management board is a multi-member management board, joint action by two members of the management board is required to submit declarations on behalf of the company.

Supervisory board

Aniela Hejnowska – Supervisory Board Member
Artur Olender – Supervisory Board Member
Marcin Fryda – Supervisory Board Member
Grzegorz Jan Głownia – Supervisory Board Member
Jacek Prusek – Supervisory Board Member

Beneficial owners

Person

Subsidiaries

NameStake
100%
100%
50%

Capital group

NameOwnership
GenXone S.A
40.31%
Genomed S.A
41.17%
Laboratorium Medyczne Optimed Kuriata, Wroński Sp. z o.o
50%

Competitors

Name
LUX Medsp. z o.o.
Copernicus Podmiot Leczniczysp. z o.o.
American Heart of PolandS.A.
PZU ZdrowieS.A.
Szpital Specjalistyczny Im. Ludwika Rydygiera w Krakowiesp. z o.o.
ScanmedS.A.
PolmedS.A.
Nutrimedsp. z o.o.
VoxelS.A.
Centrum Medyczne Luxmedsp. z o.o.

FAQ

Last updated: 2026-10-03